STOCK TITAN

Aimei Health (NASDAQ: AFJK) funds July extension with $34K note

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Aimei Health Technology Co., Ltd extended the deadline to complete its initial business combination by one month, moving the termination date from July 6, 2026 to August 6, 2026. To do this, the company deposited $34,330.96 into its trust account for public shareholders.

The deposit equals the lesser of $80,000 for all outstanding public shares or $0.033 per public share for the month and represents the twentieth permitted extension. This amount is funded by an unsecured, non‑interest‑bearing promissory note to Aimei Health Ltd, which may be converted into private units at $10.00 per unit immediately before closing the planned business combination with United Hydrogen.

Positive

  • None.

Negative

  • None.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Extension payment $34,330.96 Deposit into trust account for one-month extension
Per-share monthly extension amount $0.033 per public share Used to calculate monthly extension deposit
Alternative extension cap $80,000 Maximum amount for all outstanding public shares per month
New termination date August 6, 2026 Extended deadline to complete initial business combination
Promissory note principal $34,330.96 Unsecured note issued to Aimei Health Ltd on July 6, 2026
Conversion price $10.00 per unit Price to convert note into private units
Right conversion ratio 1/5 of one ordinary share Each right in a private unit entitles holder to this amount
Number of extensions 20th extension Twentieth extension under Articles of Association
trust account financial
"An aggregate of $34,330.96 ... has been deposited into the trust account of Aimei Health Technology Co., Ltd"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
initial business combination financial
"extend the period of time it has to consummate its initial business combination by one month"
An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.
Promissory Note financial
"the Company issued, on July 6, 2026, an unsecured promissory note in the total principal amount of $34,330.96"
A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.
Termination Date regulatory
"from July 6, 2026 to August 6, 2026 (the “Termination Date”)"
Termination date is the specific calendar day when a contract, agreement, option or other legal arrangement stops being in effect and any remaining rights or obligations expire. For investors it matters because that date sets deadlines for exercising rights, receiving payments, closing positions or avoiding penalties—similar to the day a lease or warranty ends, after which parties no longer have the same protections or claims.
emerging growth company regulatory
"Emerging growth company Item 2.03 Creation of a Direct Financial Obligation"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
private units financial
"convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001979005 0001979005 2026-07-06 2026-07-06 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2026-07-06 2026-07-06 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2026-07-06 2026-07-06 0001979005 AFJK:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-07-06 2026-07-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

July 6, 2026

Date of Report (Date of earliest event reported)

 

AIMEI HEALTH TECHNOLOGY CO., LTD

(Exact Name of Registrant as Specified in its Charter)

 

Cayman Islands   001-41880   N/A

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

10 East 53rd Street, Suite 3001

New York, NY

  10022
(Address of Principal Executive Offices)   (Zip Code)

 

86-13758131392

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, par value $0.0001 per share   AFJK   The Nasdaq Stock Market LLC
Rights, exchangeable into one-fifth of one Ordinary Share   AFJKR   The Nasdaq Stock Market LLC
Units, each consisting of one Ordinary Share and one Right   AFJKU   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

Extension of the Termination Date

 

An aggregate of $34,330.96 (the “Extension Payment”) has been deposited into the trust account of Aimei Health Technology Co., Ltd (the “Company”) for its public shareholders, representing the lessor of (i) $80,000 for all outstanding public shares and (ii) $0.033 for each outstanding public share for each monthly extension, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from July 6, 2026 to August 6, 2026 (the “Termination Date”). The Extension is the twentieth extension permitted under the Amended and Restated Articles of Association of the Company currently in effect.

 

Promissory Note

 

In connection with the Extension, the Company issued, on July 6, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “Promissory Note”) to Aimei Health Ltd, a Cayman Islands exempted company (the “Payee”), to fund the Extension Payment. The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “Business Combination”). The Payee has the right, but not the obligation, to convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth (1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company with written notices of their intention to convert the Promissory Note at least two business days prior to the closing of the Business Combination.

 

The foregoing description of the Promissory Note is not complete and is qualified in its entirety by reference to the text of such document, which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

 

Item 9.01 Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Promissory Note, dated July 6, 2026, by and among Aimei Health Technology Co., Ltd, Aimei Health Ltd, and United Hydrogen Group Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 6, 2026

 

  Aimei Health Technology Co., Ltd
     
  By: /s/ Junheng Xie
  Name: Junheng Xie
  Title: Chief Executive Officer and Director
    (Principal Executive Officer)

 

 

 

FAQ

What did Aimei Health Technology (AFJK) announce in this 8-K filing?

Aimei Health Technology extended its business combination deadline by one month to August 6, 2026. It deposited $34,330.96 into its trust account, funded by an unsecured promissory note that can be converted into private units at $10.00 per unit.

How much did Aimei Health (AFJK) contribute for the July 2026 extension?

The company deposited $34,330.96 into its trust account to fund the one-month extension. This represents the lesser of $80,000 for all public shares or $0.033 per outstanding public share for that monthly extension period.

What are the key terms of Aimei Health’s (AFJK) new promissory note?

Aimei Health issued an unsecured promissory note for $34,330.96 to Aimei Health Ltd. The note bears no interest and becomes payable when the company consummates its business combination with United Hydrogen, with an option to convert into private units at $10.00 per unit.

Can the Aimei Health (AFJK) promissory note be converted into equity?

Yes. The Payee may convert the full or partial principal into private units at $10.00 per unit. Each private unit consists of one ordinary share and one right to receive one-fifth of one ordinary share immediately before the business combination closes.

How many extensions has Aimei Health (AFJK) used under its charter?

This action represents the twentieth extension allowed under the company’s Amended and Restated Articles of Association. Each extension requires an additional deposit into the trust account tied to the number of outstanding public shares for that month.

Filing Exhibits & Attachments

5 documents